Items where authors include "Hanlon, Peter"

Article

Wightman, Heather, Butterly, Elaine, Wei, Lili et al. (11 more authors) (2025) Frailty in randomised controlled trials of glucose-lowering therapies for type 2 diabetes:An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events. Plos medicine. ISSN 1549-1277 (In Press)

Hanlon, Peter, Butterly, Elaine, Wei, Lili et al. (19 more authors) (2025) Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes A Network Meta-Analysis. JAMA. ISSN 1538-3598

Lees, Jennifer S, Crowther, Jamie, Hanlon, Peter et al. (9 more authors) (2024) Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions:meta-analysis of individual participant level data. BMJ Medicine. e000732. ISSN 2754-0413

Hanlon, Peter, Butterly, Elaine W, Shah, Anoop Sv et al. (9 more authors) (2023) Treatment effect modification due to comorbidity:Individual participant data meta-analyses of 120 randomised controlled trials. Plos medicine. e1004176. ISSN 1549-1277

Butterly, Elaine, Hanlon, Peter, Shah, Anoop S. et al. (10 more authors) (2023) Comorbidity and health related quality of life in people with a chronic medical condition in randomised clinical trials:an individual participant data meta-analysis. Plos medicine. e1004154. ISSN 1549-1277

Hanlon, Peter, Butterly, Elaine, Shah, Anoop S. et al. (7 more authors) (2022) Assessing trial representativeness using Serious Adverse Events:An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data. BMC Medicine. 410. ISSN 1741-7015

Butterly, Elaine, Wei, L, Adler, Amanda I et al. (16 more authors) (2022) Calibrating a network meta-analysis of diabetes trials of sodium glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population:a systematic review protocol. BMJ Open. e066491. ISSN 2044-6055

Lees, Jennifer S, Hanlon, Peter, Butterly, Elaine et al. (8 more authors) (2022) Effect of age, sex and morbidity count on trial attrition: meta-analysis of individual participant-level data from phase 3/4 industry-funded clinical trials. BMJ Medicine. e000217. ISSN 2754-0413

Hannigan, Laurie, Phillippo, David, Hanlon, Peter et al. (6 more authors) (2022) Improving the Estimation of Subgroup Effects for Clinical Trial Participants with Multimorbidity by Incorporating Drug Class-Level Information in Bayesian Hierarchical Models:A Simulation Study. Medical Decision Making. pp. 228-240. ISSN 1552-681X

Hanlon, Peter, Hannigan, Laurie, Rodriguez-Perez, Jesus et al. (7 more authors) (2019) Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies:an individual-level participant data analysis. BMC Medicine. 201 (2019). ISSN 1741-7015